Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma.

Woo HY, Jang JW, Choi JY, Bae SH, You CR, Rha SE, Lee YJ, Yoon SK, Lee CD.

Scand J Gastroenterol. 2010 Mar;45(3):332-9. doi: 10.3109/00365520903456573.

PMID:
20001605
2.

Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.

Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2010 Mar;17(3):869-77. doi: 10.1245/s10434-009-0788-7. Epub 2009 Dec 22.

PMID:
20033326
3.

Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.

Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K.

Am J Gastroenterol. 2009 Nov;104(11):2747-53. doi: 10.1038/ajg.2009.414. Epub 2009 Jul 14.

PMID:
19603009
4.

Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma.

Kinugasa H, Nouso K, Takeuchi Y, Yasunaka T, Onishi H, Nakamura S, Shiraha H, Kuwaki K, Hagihara H, Ikeda F, Miyake Y, Takaki A, Yamamoto K.

J Gastroenterol. 2012 Apr;47(4):421-6. doi: 10.1007/s00535-011-0492-9. Epub 2011 Nov 3. Erratum in: J Gastroenterol. 2012 Apr;47(4):489.

5.

Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.

Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.

J Hepatobiliary Pancreat Surg. 2008;15(6):627-33. doi: 10.1007/s00534-007-1341-3. Epub 2008 Nov 7.

PMID:
18987934
6.

Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.

Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, Yoon HK, Sung KB, Lee YS, Suh DJ.

J Gastroenterol Hepatol. 2002 Jan;17(1):52-8.

PMID:
11895553
8.

Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence.

Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J.

J Surg Oncol. 2000 Feb;73(2):109-14.

PMID:
10694648
9.

Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?

Golfieri R, Renzulli M, Mosconi C, Forlani L, Giampalma E, Piscaglia F, Trevisani F, Bolondi L; Bologna Liver Oncology Group (BLOG).

J Vasc Interv Radiol. 2013 Apr;24(4):509-17. doi: 10.1016/j.jvir.2012.12.013. Epub 2013 Feb 18.

PMID:
23428355
10.

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.

Xi T, Lai EC, Min AR, Shi LH, Wu D, Xue F, Wang K, Yan Z, Xia Y, Shen F, Lau WY, Wu MC.

Hepatogastroenterology. 2012 Jun;59(116):1198-203. doi: 10.5754/hge09654.

PMID:
22580673
11.

Clinical management of recurrent hepatocellular carcinoma.

Lee PH, Lin WJ, Tsang YM, Hu RH, Sheu JC, Lai MY, Hsu HC, May W, Lee CS.

Ann Surg. 1995 Nov;222(5):670-6.

12.

Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.

Zu QQ, Liu S, Zhou CG, Yang ZQ, Xia JG, Zhao LB, Shi HB.

AJR Am J Roentgenol. 2015 Jun;204(6):1322-8. doi: 10.2214/AJR.14.13343.

PMID:
26001244
13.

Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.

Kang JW, Kim JH, Ko GY, Gwon DI, Yoon HK, Sung KB.

Acta Radiol. 2012 Jun 1;53(5):545-50. doi: 10.1258/ar.2012.110476. Epub 2012 Apr 30.

PMID:
22547388
14.

Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.

Imai N, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H.

Oncology. 2011;80(3-4):188-94. doi: 10.1159/000328749. Epub 2011 Jun 27.

PMID:
21709428
15.
17.

Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11. doi: 10.1016/j.ijrobp.2011.03.019. Epub 2011 May 27.

PMID:
21621346
18.

[Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].

Ge NL, Ren ZG, Ye SL, Lin ZY, Xia JL, Gan YH, Li LX, Shen YF, Tang ZY.

Zhonghua Zhong Liu Za Zhi. 2005 Jun;27(6):380-2. Chinese.

PMID:
16117905
19.

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Otto G, Herber S, Heise M, Lohse AW, M├Ânch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.

Liver Transpl. 2006 Aug;12(8):1260-7.

20.

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.

Zhong C, Guo RP, Li JQ, Shi M, Wei W, Chen MS, Zhang YQ.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1437-45. doi: 10.1007/s00432-009-0588-2. Epub 2009 May 1.

PMID:
19408012

Supplemental Content

Support Center